Clinical Trial Update: SIMpill Medication Dispensing Device in the Treatment of HCV

View source ↗

Summary

The clinical trial evaluating the SIMpill Medication Dispensing Device for chronic hepatitis C infection has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Snippet

Sponsor: University of Chicago | Conditions: Chronic Hepatitis C Virus | Status: WITHDRAWN